NASDAQ: TLRY
Last close prices updated as of
Jun 08, 2023, 4:00 PM EST
| USD | BATS BZX Real-Time Price
- Last Close 1.67
- Sector Healthcare
- Industry Drug Manufacturers - Specialty & Generic
- Investment Style Small Value
- Day Range 1.65 – 1.73
- Year Range 1.63 – 5.12
- Market Cap 1.0964 Bil
- Volume / Avg 23.6 Mil / 12.9 Mil
- Price / Sales 1.67
- Price / Book 0.33
- Forward Div Yield —
- Trailing Div Yield —
Morningstar‘s Stock Analysis TLRY
Valuation
Currency in —
Is it the right time to buy or sell?
Is it the right time to buy or sell?
1-Star Price
INVESTOR
5-Star Price
INVESTOR
Economic Moat
INVESTOR
Capital Allocation
INVESTOR
Tilray: Shares Plunge on Dilutive Convertible Notes Offering, but Magnitude Is an Overreaction
Unlock Our Full Analysis With Morningstar Investor
Company Profile TLRY
Business Description
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. U.S. exposure consists of CBD products through Manitoba Harvest and beer through SweetWater.
Related Articles TLRY
Morningstar analysts hand-select direct competitors or comparable companies to provide context on the strength and durability of TLRY’s competitive advantage.
Tilray Brands Inc
XNAS: TLRY
| Aurora Cannabis Inc
XTSE: ACB
| Canopy Growth Corp
XTSE: WEED
| Cronos Group Inc
XTSE: CRON
| |
Price
| 1.67 | 0.69 | 0.92 | 2.25 |
Currency
| USD | CAD | CAD | CAD |
Change
| −$0.06 (3.47%) | −$0.01 (1.43%) | −$0.06 (6.12%) | −$0.05 (2.17%) |
Market Cap
| 1.10 Bil | 235.28 Mil | 479.32 Mil | 856.84 Mil |
Industry
| Drug Manufacturers - Specialty & Generic | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - Specialty & Generic |
Sector
|
Healthcare
|
Healthcare
|
Healthcare
|
Healthcare
|
* Trading data in this section is delayed by at least 15 minutes.
FAQs for Tilray Brands Inc Stock
No. TLRY does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks,
to compare the relationship between a stock’s price and how it rewards stockholders through dividends.
The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.
Learn more about dividend yield.
TLRY’s market cap is 1.10 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares.
It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the
largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.
Learn more about market capitalization.
TLRY’s stock style is Small Value.
Style is an investment factor that has a meaningful impact on investment risk and returns.
Style is calculated by combining value and growth scores, which are first individually calculated.
High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.
Learn more about style.
TLRY’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.
Compare TLRY’s historical performance against its industry peers and the overall market.